HealthTree Podcast for Multiple Myeloma

HealthTree Podcast for Multiple Myeloma brings you patient-led interviews of the world's top multiple myeloma researchers. Call in live at showtime to (347) 637-2631 ask questions and to learn about the latest innovation in simple terms patients can understand.

https://www.blogtalkradio.com/myelomacrowdradio

Eine durchschnittliche Folge dieses Podcasts dauert 1h6m. Bisher sind 311 Folge(n) erschienen. .

Gesamtlänge aller Episoden: 14 days 8 hours 1 minute

subscribe
share






Myeloma Crowd Radio: Ivan Borrello, MD, Johns Hopkins School of Medicine


How can we use our own immune system to fight myeloma? Using MILs (or marrow infiltrating lymphocytes)


share








 December 27, 2016  20m
 
 

Myeloma Crowd Radio: Craig Cole, MD, University of Michigan


What can data analytics do for progress in multiple myeloma? New precision medicine project underway.


share








 November 17, 2016  1h18m
 
 

Myeloma Crowd Radio: Craig Cole, MD, University of Michigan


What can data analytics do for progress in multiple myeloma? New precision medicine project underway.


share








 November 17, 2016  1h18m
 
 

Myeloma Crowd Radio: Dr. Sergio Giralt, MD, Memorial Sloan Kettering Cancer Ctr


What can be added to stem cell transplant to make it even better?


share








 November 11, 2016  1h3m
 
 

Myeloma Crowd Radio: Dr. Sergio Giralt, MD, Memorial Sloan Kettering Cancer Ctr


What can be added to stem cell transplant to make it even better?


share








 November 11, 2016  1h3m
 
 

Myeloma Crowd Radio: Nikoletta Lendvai, MD, PhD, Memorial Sloan Kettering


Everything you wanted to know about myeloma clinical trials


share








 October 28, 2016  1h8m
 
 

Myeloma Crowd Radio: Nikoletta Lendvai, MD, PhD, Memorial Sloan Kettering


Everything you wanted to know about myeloma clinical trials


share








 October 28, 2016  1h8m
 
 
share








 October 19, 2016  1h17m
 
 
share








 October 19, 2016  1h17m
 
 

Myeloma Crowd Radio: Dr. Torben Plesner, Vejle Hospital, Denmark


What's are the issues being on the new daratumumab? A myeloma expert weighs in with his findings.


share








 September 28, 2016  1h18m